¤K¤Q¤K¦~«×¤º¬ì±M¬ìÂå®v¦Ò¸Õµ§¸ÕÃD -- ¸~½F¬ì

(E) 1.¤Æ¾ÇªvÀøÃĪ«¬Û¹ïÀ³ªº°Æ§@¥Î¡A¤U¦C°t¹ï¦óªÌ¿ù»~¡H
A.Paclitaxel: peripheral neuropathy
B.Bleomycin: pulmonary toxicity
C.Fluorouracil: hand-foot syndrome
D.Cisplatin: ototoxicity
E.Mitoxantrone: hemolytic-uremic syndrome
 
(B) 2.¦³Ãö¸~½FªþÄݯg­Ô¸s(paraneoplastic syndrome)¡A¤U¦C±Ô­z¦óªÌ¿ù»~¡H
A.±`»P¸~½F²Ó­M¤£·í¤Àªc¦hÐ`úT²üº¸»X(polypeptide hormone)¦³Ãö
B.­GÀù¬O¤Þµoectopic ACTH syndrome¤¤³Ì±`¨£ªº­ì¦]
C.µÇ²Ó­MÀù»Perythrocytosis¦³Ãö
D.¤p²Ó­MªÍÀù»PLambert-Eaton myasthenic syndrome¦³Ãö
E.¸¢Àù¥i¤Þ°_Äjº©©Ê¦åºÞ¤º¦å²G¾®©T¯g(disseminated intravascular coagulation)
 
(A) 3.56·³¨k©Ê¯f¤H¡A¦]«K¦å¤ÎÅé­«´î»´´NÂå¡A¤j¸zÃèÀˬdµo²{ª½¸z¤º¦³¤@2 cm¤§¸~¶ô¡A¸g¤Á¤ùÃҹꬰadenocarcinoma¡A¤U¦C±Ô­z¦óªÌ¿ù»~¡H
A.­Y¦P®Éµo²{¨xŦ¤º¦³Âಾ©Ê¯f¨_¡AÀ³¶i¦æ¥þ¨­©Ê¤Æ¾ÇªvÀø¡A¤£¶·¦Ò¼{¤â³N
B.¥þ¨­©ÊÀˬd¡A­YµL¨ä¥LÂಾ©Ê¯f¨_¡AÀ³¹ê¬I¤â³N¤Á°£
C.­YÃҹꬰDuke B2 or C¤§ª½¸zÀù¡AÀ³¦X¨Ö³N«á¤Æ¾ÇªvÀø©M§½³¡©ñ®g½uªvÀø
D.­Y¥u¦³³æ¤@ªÍ³¡Âಾ©Ê¯f¨_¡A¨Ã¥i¤â³N¤Á°£¡A«h¤Á°£«á¤´¦³ªø´Á¦s¬¡ªº¾÷·|
E.¹ï©ó´_µo©ÎÂಾ¤§ª½¸zÀù¡A­Y¿ï¾Ü¤Æ¾ÇªvÀø¡AÀ³¦Ò¼{5-fluorouracil¬°¥D¤§ªvÀø
 
(C) 4.52·³«D¤p²Ó­MªÍÀù¤§¯f¤H¦]·NÃÑ»Ùê¡A³Q®a¤H°e¨ì«æ¶E´NÂå¡A¦å²GÀˬdÅã¥Ü calcium: 3.8 mmol/L¡A¤U¦C±Ô­z¦óªÌ¿ù»~¡H
A.¤j¶q¸É¥R¥Í²z­¹ÆQ¤ô¡A¨ÃÀH®É°»´ú¦å¤¤¶tÂ÷¤l¿@«×
B.¥i¦Ò¼{¨Ï¥ÎbisphosphonatesªvÀø
C.¥i¯à»P¸~½F¤ÀªcªºPTH (parathyroid hormone) ¦³Ãö
D.«æ©Ê´Á¥i¦Ò¼{¨Ï¥ÎcalcitoninªvÀø
E.¥i¯à»P¸~½FÂಾ¦Ü°©ÀY¦³Ãö
 
(B) 5.48·³¤k©Ê¯f¤H¡A¤T¦~«e¦]¥k°¼¨ÅÀù¡A±µ¨ü¨Å©Ð®Ú°£¤â³N¡C¸~½F¤§°Ê±¡¿E¯À±µ¨üÅé (estrogen receptor) ¬°¶§©Ê¡C¯f¤H¥¼±µ¨ü¥ô¦ó»²§U©ÊªvÀø¡C³Ìªñ¦]¤U­I³¡¯kµh´NÂå¡A¥þ¨­Àˬd°£¸y´Õ¦³Âಾ¤§¯f¨_¥~¡A¨ä¥L¨ÃµLÂಾ¡C¤U¦C±Ô­z¦óªÌ¿ù»~¡H
A.¥i¦Ò¼{²üº¸»XªvÀø
B.­Y²üº¸»XªvÀø¯f±¡±o¨ì½w¸Ñ¡A¦ý¤@¬q®É¶¡«á¦A´c¤Æ¡A¦A¨Ï¥Î²Ä¤G½u²üº¸»XªvÀø³q±`µL®Ä
C.­Y¦X¨Ö¨ä¥LÂಾ¤§¯f¨_¨Ã¦³¥ß§Y¥Í©R¦MÀI¡AÀ³¦Ò¼{¤Æ¾ÇªvÀø
D.­Y¸y´Õµo¥Í¯f²z©Ê°©§é¡A¥i¦Ò¼{¤â³N©T©w
E.­Y°©ÀY¯kµh«ùÄò¡A¥i¦Ò¼{½w¸Ñ©Ê§½³¡©ñ®g½uªvÀø
 
(A) 6.22·³¨k©Ê¦]¯Ýµh¤Î©I§l§xÃø¦Ü«æ¶E³B¡A¯Ý³¡X¥úÅã¥Ü«eÁa»JµÄ¦³¤@ 6x4 cm¤§¸~¶ô¡A¤Á¤ùÃҹꬰ¤À¤Æ¤£¨}©ÊÀù¯g(poorly-differentiated carcinoma)¡C¤U¦C±Ô­z¦óªÌ¿ù»~¡H
A.¤£¶·¶i¤@¨B¶i¦æ¸A¤Y¤§²z¾ÇÀˬd©Î¶W­µªiÀˬd
B.¥i¯à»P chromosome 12 ²§±`¦³Ãö
C.¦å²GÀˬd¡G£\-FP or £]-hCG¥iÀ°§UŲ§O¶EÂ_
D.À³§ë¤©cisplatin¬°¥Dªº¥þ¨­©Ê¤Æ¾ÇªvÀø
E.¤Æ¾ÇªvÀø«á¡A­Y¸~½F¼Ð°O«ì´_¥¿±`¡A¦ý¼v¹³Àˬd¤´¦³³Ñ¾l¸~½F®É¡A¥i¦Ò¼{¤â³N¤Á°£
 
(D) 7.¤U¦C¦³Ãö­G¤Î¤p¸z²O¤Ú½Fªº±Ô­z¡A¦óªÌ¿ù»~¡H
A.Mucosa-associated lymphoid tissue lymphoma (MALToma) of stomach »P H. pylori ·P¬V¦³Ãö
B.Immunoproliferative small intestinal disease (IPSID)¡A±`¦³¸¡Âm©MÀç¾i¤£¨}¤§¯gª¬
C.¤j¦h¬O B-cell ¨Ó·½
D.§Ü¥Í¯À¨Ã¤£¯à¥Î¨ÓªvÀø MALToma or IPSID
E.°ª´c©Ê«×(high-grade)¤§­G¤Î¤p¸z²O¤Ú½F¡AÀ³§ë¤©¥þ¨­©Ê¤Æ¾ÇªvÀø
 
(D) 8.¤U¦C¦³Ãö¸~½F¼Ð°O¬Û¹ïÀ³ªºÀù¯g¡A¦óªÌ¿ù»~¡H
A.PSA: prostate cancer
B.Calcitonin: medullary cancer of the thyroid
C.CEA: colon, breast or lung cancer
D.CA-125: pancreatic cancer or cholangiocarcinoma
E.Alpha-fetoprotein: hepatocellular carcinoma or germ cell tumor
 
(C) 9.52·³°±¸g¤k©Ê¡A¤­¦~«e±µ¨ü¥k°¼¨Å©Ð¤Á°£¡A¯f²zÃҹꬰinfiltrating ductal carcinoma¡A°Ê±¡¿E¯À±µ¨üÅé(estrogen receptor)¬°¶§©Ê¡AµLµÅ¤U²O¤Úµ²«I¥Ç¡A³N«á¨Ã¥¼±µ¨ü¥ô¦ó»²§U©ÊªvÀø¡C¦¹¦¸¦]¥k¤j»L¯kµh¨Ã¼vÅT¦æ¨«¡A¬G¦Ü«æ¶E´NÂå¡A¢æ¥úÅã¥Ü¥k»ë°©ÀV³¡(femoral neck)¦³¤@3.5 cmª½®|¤§»k°©©Ê¯f¨_¡C¥þ¨­©Ê¼v¹³Àˬd¨Ã¥¼µo²{¦³¨ä¥¦¤§Âಾ¡C¤U¦CªvÀø¡A¦óªÌ³Ì¾A©y1. Tamoxifen2. ¤Æ¾ÇªvÀø3. ©ñ®g½uªvÀø4. ¹w¨¾©Ê°©ÀY©T©w5. §Z±_¤Á°£
A.1, 2
B.1, 2, 3
C.1, 3, 4
D.3, 5
E.2, 3, 4
 
(D) 10.¤U¦C¦óºØÀù¯g¤´¨S¦³¤½»{¦³®Ä(©µªø¯f¤HÁ`¦s¬¡²v)¤§¤â³N«á»²§U©Ê¤Æ¾ÇªvÀø(adjuvant chemotherapy)¡H1. ¨ÅÀù¨Ö¦P°¼µÅ¤U²O¤Úµ²Âಾ2. ­GÀù¨Ö§½³¡²O¤Úµ²Âಾ3. «Dºë²Ó­M¥Í´Þ²Ó­MÀù(Nonseminomatous germ cell tumor)¨Öª½®|¤j©ó5¤½¤À¤§«á¸¡µÄ²O¤Úµ²Âಾ4. °©·½©Ê¦×½F(Osteogenic sarcoma)5. µÇ²Ó­MÀù(Renal cell carcinoma)
A.2, 4, 5
B.3, 5
C.1, 2, 5
D.2, 5
E.2, 3, 5
 


< ¤K¤Q¤K¦~«×¸ÕÃD¥Ø¿ý >